Franklin Resources
INDV icon

Franklin Resources’s Indivior Pharmaceuticals INDV Stock Holding History

Franklin Resources’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$136M Buy
3,316,358
+3,204,765
+2,872% +$116M 0.03% 384
2026
Q1 		$3.4M Buy
111,593
+8,869
+9% +$293K ﹤0.01% 1696
2025
Q4 		$3.68M Buy
102,724
+44,614
+77% +$1.36M ﹤0.01% 1540
2025
Q3 		$1.4M Buy
+58,110
New +$1.22M ﹤0.01% 1934

Other funds holding INDV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
OCM
Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.32B AUM 132.6% 1-Year Est. Return

Franklin Resources's INDV Position: Q2 2026 in Review

Franklin Resources increased its Indivior Pharmaceuticals (INDV) stake by 2,872% in Q2 2026, buying an estimated $116M and bringing the position to 3,316,358 shares worth $136M. The position accounts for 0.03% of the portfolio, ranked #384.

Franklin Resources first reported a position in INDV in Q3 2025 and has held it in 4 quarters since. 338 funds tracked by Wall St. Rank hold INDV as of Q2 2026.

  • Franklin Resources held 3,316,358 shares of Indivior Pharmaceuticals worth $136M as of Q2 2026.
  • Franklin Resources bought 3,204,765 Indivior Pharmaceuticals shares in Q2 2026, an estimated $116M.
  • Indivior Pharmaceuticals made up 0.03% of Franklin Resources's portfolio in Q2 2026, its #384 holding.
  • Franklin Resources first reported a position in Indivior Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • 338 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q2 2026.

Based on Franklin Resources's 13F filing for Q2 2026, filed 13 Aug 2026.